"A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma" by Yazmin Odia

Article

A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

All Publications

Yazmin Odia, Miami Cancer Institute
Minesh Mehta, Miami Cancer Institute

Find in your library

Publication Date

6-1-2021

Presented At:

2021 ASCO Annual Meeting

Content Type

Presentation

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

Citation Information

Yazmin Odia and Minesh Mehta. "A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma" (2021)
Available at: http://works.bepress.com/minesh-mehta/496/